Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007063
Filing Date
2025-05-09
Accepted
2025-05-09 07:04:04
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20250331x10q.htm   iXBRL 10-Q 793770
2 EX-3.7 plx-20250331xex3d7.htm EX-3.7 166470
3 EX-31.1 plx-20250331xex31d1.htm EX-31.1 12462
4 EX-31.2 plx-20250331xex31d2.htm EX-31.2 12631
5 EX-32 plx-20250331xex32.htm EX-32 6697
6 EX-32.2 plx-20250331xex32d2.htm EX-32.2 6725
7 GRAPHIC plx-20250331x10q005.jpg GRAPHIC 76005
8 GRAPHIC plx-20250331x10q006.jpg GRAPHIC 58451
9 GRAPHIC plx-20250331x10q007.jpg GRAPHIC 52258
10 GRAPHIC plx-20250331x10q008.jpg GRAPHIC 38391
11 GRAPHIC plx-20250331x10q009.jpg GRAPHIC 56626
12 GRAPHIC plx-20250331x10q010.jpg GRAPHIC 40218
  Complete submission text file 0001558370-25-007063.txt   4424971

Data Files

Seq Description Document Type Size
13 EX-101.SCH plx-20250331.xsd EX-101.SCH 25542
14 EX-101.CAL plx-20250331_cal.xml EX-101.CAL 36474
15 EX-101.DEF plx-20250331_def.xml EX-101.DEF 85607
16 EX-101.LAB plx-20250331_lab.xml EX-101.LAB 189850
17 EX-101.PRE plx-20250331_pre.xml EX-101.PRE 156826
58 EXTRACTED XBRL INSTANCE DOCUMENT plx-20250331x10q_htm.xml XML 376195
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 25928332
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)